Aurora Cannabis (ACB) Net Cash Flow Growth (3y) (2020 - 2025)
Aurora Cannabis (ACB) Net Cash Flow Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.84 Bn | 32.10 Bn | 1.97 Bn | 32.03% |
| 3 | Zoetis | 32.67 Bn | 30.73 Bn | 1.62 Bn | 28.99% |
| 4 | Takeda Pharmaceutical | 27.69 Bn | 23.63 Bn | 4.39 Bn | 37.89% |
| 5 | United Therapeutics | 23.12 Bn | 20.97 Bn | 648.10 Mn | -49.94% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.24 Bn | 18.44 Bn | 1.16 Bn | 37.74% |
| 8 | Neurocrine Biosciences | 17.83 Bn | 16.51 Bn | 800.70 Mn | -41.05% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.22 Bn | 785.00 Mn | -62.71% |
| 10 | Aurora Cannabis | 153.98 Mn | 68.73 Mn | 21.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 28.40% |
| Mar 31, 2025 | -60.74% |
| Dec 31, 2024 | 22.42% |
| Sep 30, 2024 | 40.35% |
| Jun 30, 2024 | 30.14% |
| Mar 31, 2024 | -32.55% |
| Dec 31, 2023 | -59.74% |
| Sep 30, 2023 | -6.99% |
| Dec 31, 2022 | -271.33% |
| Sep 30, 2022 | -62.50% |
| Jun 30, 2022 | 82.56% |
| Mar 31, 2022 | -25.12% |
| Dec 31, 2021 | -54.16% |
| Sep 30, 2021 | -36.80% |
| Jun 30, 2021 | -27.32% |
| Mar 31, 2021 | 30.95% |
| Dec 31, 2020 | 2.42% |
| Sep 30, 2020 | 9.55% |